Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 1, Issue 6 (2012)

A Formulation and Development of Orodispersible Tablet of Lornoxicam

Author(s):
Sanjay Wasudeo Upare, Dr. A. V. Chandewar, Dr. M. D. Kshirsagar, Mr. U. S. Koli and Mr. H. K. Pokale
Abstract:
Lornoxicam is a non-steroidal anti-inflammatory drug with analgesic properties. The purpose of this study was to develop a taste masked oral disintegrating tablet of poorly soluble Lornoxicam by direct compression technique with β-cyclodextrin (BCD) complexes using various super disintegrants like sodium starch glycolate, crospovidone and L-Hpc. Prepared tablets were evaluated for different properties like drug content, hardness, friability, disintegration time and in vitro dissolution study. The different formulations showed disintegration time between 21 to 33.66 s. Drug release showed time between the ranges of 5 to 30 min. Among all the formulations, L1 showed 97.79% drug release within 30 min. Thus, L1 was considered best among the other formulations. The tablets showed enhanced dissolution hence better patient compliance.
Pages: 50-62  |  1673 Views  33 Downloads


The Pharma Innovation Journal
How to cite this article:
Sanjay Wasudeo Upare, Dr. A. V. Chandewar, Dr. M. D. Kshirsagar, Mr. U. S. Koli, Mr. H. K. Pokale. A Formulation and Development of Orodispersible Tablet of Lornoxicam. Pharma Innovation 2012;1(6):50-62.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal